STUDY OF PROTECTIVE ACTIVITY OF «STAPHYLOVAC-2» VACCINE
- Authors: Gruber I.M1, Egorova N.B1, Mikhailova N.A1, Cherkasova L.S1, Tarasova O.E1, Astashkina E.A1, Ignatova O.M1, Kurbatova E.A1
-
Affiliations:
- Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
- Issue: Vol 91, No 6 (2014)
- Pages: 54-58
- Section: Articles
- Submitted: 09.06.2023
- Published: 15.12.2014
- URL: https://microbiol.crie.ru/jour/article/view/14009
- ID: 14009
Cite item
Full Text
Abstract
Keywords
About the authors
I. M Gruber
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
N. B Egorova
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
N. A Mikhailova
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
L. S Cherkasova
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
O. E Tarasova
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
E. A Astashkina
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
O. M Ignatova
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
E. A Kurbatova
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
References
- Ашмарин И.П., Воробьев А.А. Статистические методы в микробиологических исследованиях. Л., Медгиз, 1962.
- Гланц С.А. Медико-биологическая статистика. М., Практика, 1999.
- Грубер И.М., Егорова Н.Б., Курбатова Е.А., Михайлова Н.А. Стратегия разработки противостафилококковых иммунопрофилактических и иммунотерапевтических препаратов. Эпидемиол. инфекц. бол. Актуальные вопросы. 2013, 4: 31-38.
- Ефремова В.Н., Егорова Н.Б., Масюкова С.А. Бесклеточная антистафилококковая вакцина для лечения хронической стафилококковой инфекции. Патент на изобретение № 2122862 от 10.12.1998.
- Егорова Н.Б., Ефремова В.Н., Курбатова Е.А., Грубер И.М. Экспериментальная и клинико-иммунологическая оценка бесклеточной стафилококковой вакцины «Стафиловак». Журн. микробиол. 2008, 6: 102-108.
- Bubeck W.J., Palazzolo-Ballance A.M., Otto M. et al. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J. Infect. Dis. Oct. 2008, 198 (8): 1166-1170.
- Etz H., Minh D.B., Henics T. et al. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc. Natl. Acad. Sci. USA. 2002, 99 (10): 6573-6578.
- Lee S.S., Kim Y.J., Chung D.R., et al. Invasive infection caused by community-associated methicillin-resistant strain not carrying Panton-valentine leukocidin in Korea. J. Clin. Microbiol. 2009, 48 (1): 311-313.
- Medzhitov R., Janeway Jr. C.A. Innate immune induction of the adaptive immune response. Cold Spring. Harb. Symp. Quant. Biol. 2002, 64: 429-435.
- Otto M. Novel targeted immunotherapy approaches for staphylococcal infection. Expert. Opin. Biol. Ther. 2010, 10 (7): 1049-1059.
- Rosengren A.T., Nyman T.A., Lashesman R. Proteonic profiling of interleukine 12 treated human T-helper cells. Proteomics. 2005, 5 (12): 3137-3141.
Supplementary files
![](/img/style/loading.gif)